Aristea
is a California-based biotechnology firm that develops and commercializes novel therapies for the treatment of inflammatory diseases... Read moreAristea
is a California-based biotechnology firm that develops and commercializes novel therapies for the treatment of inflammatory diseases... Read more
News
Feb 14, 2023
Contract Pharma
Aristea: Aristea Therapeutics Discontinues RIST4721 Development Program, Dissolves Company
Nov 02, 2022
Benzinga
Aristea: Aristea Therapeutics Strengthens its Team with Appointments of Executive Medical Director and Two Clinical Scientists as Clinical Programs Progress
Sep 02, 2022
Pharmabiz
Aristea: Aristea begins patient dosing in phase 2a trial of RIST4721 in hidradenitis suppurativa
Jul 12, 2022
MedCity News
Aristea: Areteia gets $350M to turn failed ALS drug into a therapy for severe asthma
Jun 30, 2022
Markets Insider
Aristea: Aristea Therapeutics Announces Dosing of First Patient in Open-Label Extension for Phase 2b Trial of RIST4721 in Palmoplantar Pustulosis
Mar 28, 2022
PR Newswire
Press Release: Aristea : Aristea Therapeutics Announces Dosing of First Patient in Phase 2b Trial of RIST4721 in Palmoplantar Pustulosis
Jan 13, 2022
Markets Insider
Aristea: Aristea Therapeutics Announces Key Leadership Appointments to Advance Its Clinical Pipeline
Sep 20, 2021
Markets Insider
Aristea: Aristea Therapeutics to Present at Upcoming Investor Conferences
Jul 30, 2021
Global Legal Chronicle
Aristea: Arena Pharmaceuticals' Strategic Collaboration with Aristea Therapeutics
Jul 27, 2021
BioPharma Dive
Aristea: An AstraZeneca spinout scores a buyout option from Arena
